(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRILURON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TRILURON

ST13

US500000079257832

Class

5, 10

Filing

79257832

Registration

5969841

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

04/28/2026

Trademark type

Word

Nice classes

5, 10

Filing date

11/29/2018

Registration date

01/28/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/08/2026

Last transaction

04/28/2026

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

4

Owner type

09

Owner location

Abano Terme (PD), IT

Examiner

SMIGA, HOWARD

Current location

Historical data usage

Holders and representatives

Holders

FIDIA FARMACEUTICI S.p.A.
FIDIA FARMACEUTICI S.p.A.

Representatives

Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals and medical preparations for the treatment of the jointsfor traumatic and degenerative joint pathologies and for use during orthopedic surgery; pharmaceutical preparations for the treatment of rheumatologic diseases; analgesic preparations; pharmaceutical preparations for the treatment of diseases of the muscular and skeletal system; pre-filled syringes for medical use filled with analgesic preparationspreparations for the treatment of the jointsfor traumatic and degenerative joint pathologiesfor use during orthopedic surgeryfor the treatment of rheumatologic diseases and for the treatment of diseases of the muscular and skeletal system

Class 10

Medical syringes; cannulae; applicators and medical devices for the administration of pharmaceutical preparationsnamely injection devices for pharmaceuticals and medical preparations; medico-surgical devices for the treatment of degenerative and traumatic joints and musculoskeletal apparatus and for use during orthopedic surgery

Publications

History of USPTO decisions and trademark events.

33 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

04/08/2026

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

04/08/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/06/2026

ES71

TEAS SECTION 71 RECEIVED

12/04/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/28/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/29/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/11/2020

FIMP

FINAL DISPOSITION PROCESSED

05/11/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/28/2020

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

03/06/2020

GPNX

NOTIFICATION PROCESSED BY IB

02/07/2020

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/30/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

01/28/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/12/2019

PUBO

PUBLISHED FOR OPPOSITION

11/12/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/23/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/23/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/23/2019

ALIE

ASSIGNED TO LIE

10/10/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/07/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/09/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/08/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/08/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/08/2019

RFNT

REFUSAL PROCESSED BY IB

06/22/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/02/2019

RFRR

REFUSAL PROCESSED BY MPU

06/02/2019

MAFR

APPLICATION FILING RECEIPT MAILED

05/10/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/07/2019

CNRT

NON-FINAL ACTION WRITTEN

05/06/2019

DOCK

ASSIGNED TO EXAMINER

05/06/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/06/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/02/2019

Continuous trademark protection

Get notified about every new filing that threatens TRILURON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.